@entity2969 ( @entity2969 ), which comprise 98% of all @entity5 , are the most commonly occurring @entity5 among @entity1 between the ages of 15 and 44  years in the United States (US). A prior report from our group found that while @entity2969 incidence among all US @entity1 increased between 1973 and 2003, the rate of increase among black @entity1 was more pronounced starting in 1989-1993 than was the rate of increase among other @entity1 . In addition, @entity2969 incidence increased among Hispanic white @entity1 between 1992 and 2003. To determine whether these patterns have continued, in the current study, we examined temporal trends in incidence through 2011. Between 1992 and 2011, 21  271 TGCTs (12  419 @entity4797 ; 8715 @entity4797 ; 137 @entity2969 ) were diagnosed among residents of the Surveillance, Epidemiology, and End Results 13 registry areas. The incidence of @entity2969 was highest among non-Hispanic white @entity1 (6.97 per 100  000 @entity1 -years) followed by American Indian/Alaska Native (AI/AN; 4.66), Hispanic white (4.11), Asian/Pacific Islander (A/PI; 1.95), and black (1.20) @entity1 . Non-Hispanic white @entity1 were more likely to present with smaller @entity5 (3.5  cm) and localized disease (72.6%) than were @entity1 of other races/ethnicities. Between 1992 and 2011, @entity2969 incidence increased significantly among Hispanic white [annual percent change (APC)  =  2.94, p  <  0.0001], black (APC  =  1.67, p  =  0.03), non-Hispanic white (APC  =  1.23, p  <  0.0001), and A/PI (APC  =  1.04, p  =  0.05) @entity1 . Incidence rates also increased, although not significantly, among AI/AN @entity1 (APC  =  2.96, p  =  0.06). The increases were greater for non- @entity4797 than @entity4797 . In summary, while non-Hispanic white @entity1 in the US continue to have the highest incidence of @entity2969 , they present at more favorable stages of disease and with smaller @entity5 than do other @entity1 . The increasing rates among non-white @entity1 , in conjunction with the larger proportion of non-localized stage disease, suggest an area where future research is warranted.

Recent trends in the incidence of XXXX in the United States.

@entity5 :: ('MESH:D009369', 'Disease') :: ['testicular malignancies', 'tumors', 'cancers'] @entity1 :: ('9606', 'Species') :: ['man', 'men'] @entity2969 :: ('MESH:C563236', 'Disease') :: ['Testicular germ cell tumors', 'spermatocytic seminomas', 'TGCT'] @entity4797 :: ('MESH:D018239', 'Disease') :: ['seminomas', 'seminoma', 'non-seminomas']
@entity2969 :: (MESH:C563236,Disease) :: ['testicular germ cell tumors']
